View in EDS HTML Full Text PDF Full Text

Development of Fully Human Antibodies Targeting SIRPα and PLA2G7 for Cancer Therapy.

Saved in:
Bibliographic Details
Title: Development of Fully Human Antibodies Targeting SIRPα and PLA2G7 for Cancer Therapy.
Authors: Shin S; Center for Antibody Therapeutics, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA., Baek DS; Center for Antibody Therapeutics, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.; GLPG US, 1401 Forbes Avenue, Pittsburgh, PA 15219, USA., Mellors JW; Center for Antibody Therapeutics, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.; GLPG US, 1401 Forbes Avenue, Pittsburgh, PA 15219, USA., Dimitrov DS; Center for Antibody Therapeutics, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.; GLPG US, 1401 Forbes Avenue, Pittsburgh, PA 15219, USA., Li W; Center for Antibody Therapeutics, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Source: Antibodies (Basel, Switzerland) [Antibodies (Basel)] 2025 Mar 03; Vol. 14 (1). Date of Electronic Publication: 2025 Mar 03.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101587489 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4468 (Electronic) Linking ISSN: 20734468 NLM ISO Abbreviation: Antibodies (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40136470
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Development of Fully Human Antibodies Targeting SIRPα and PLA2G7 for Cancer Therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shin+S%22">Shin S</searchLink>; Center for Antibody Therapeutics, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.<br /><searchLink fieldCode="AU" term="%22Baek+DS%22">Baek DS</searchLink>; Center for Antibody Therapeutics, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.; GLPG US, 1401 Forbes Avenue, Pittsburgh, PA 15219, USA.<br /><searchLink fieldCode="AU" term="%22Mellors+JW%22">Mellors JW</searchLink>; Center for Antibody Therapeutics, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.; GLPG US, 1401 Forbes Avenue, Pittsburgh, PA 15219, USA.<br /><searchLink fieldCode="AU" term="%22Dimitrov+DS%22">Dimitrov DS</searchLink>; Center for Antibody Therapeutics, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.; GLPG US, 1401 Forbes Avenue, Pittsburgh, PA 15219, USA.<br /><searchLink fieldCode="AU" term="%22Li+W%22">Li W</searchLink>; Center for Antibody Therapeutics, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101587489%22">Antibodies (Basel, Switzerland)</searchLink> [Antibodies (Basel)] 2025 Mar 03; Vol. 14 (1). <i>Date of Electronic Publication: </i>2025 Mar 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI+AG%22">MDPI AG </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101587489 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2073-4468 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220734468%22">20734468 </searchLink><i>NLM ISO Abbreviation: </i>Antibodies (Basel) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40136470
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/antib14010021
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Development of Fully Human Antibodies Targeting SIRPα and PLA2G7 for Cancer Therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shin S
      – PersonEntity:
          Name:
            NameFull: Baek DS
      – PersonEntity:
          Name:
            NameFull: Mellors JW
      – PersonEntity:
          Name:
            NameFull: Dimitrov DS
      – PersonEntity:
          Name:
            NameFull: Li W
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 03
              Text: 2025 Mar 03
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2073-4468
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Antibodies (Basel, Switzerland)
              Type: main
ResultId 1